Tagged: bn201

Capital Cell Celebrates Bionure’s Recordbreaking Spanish Biotech Crowdfunding Campaign, Plans UK Launch

Bionure, a Spanish biotech company developing a  first-in-class drug for the treatment of multiple sclerosis, is currently 115% overfunding on Capital Cell. With more than €1,100,246 raised, Bionure has broken the record for the highest amount raised on a Spanish life science equity crowdfunding platform. Valued at… Read More

Send this to a friend